Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cd4+ Lymphocyte Deficiency”

164 trials

Showing 20 of 164 results

Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Not applicableStudy completedNCT02934022
What this trial is testing

Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients

Who this might be right for
HIV Infection
Southern California Institute for Research and Education 25
Early research (Phase 1)Study completedNCT00002129
What this trial is testing

A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3

Who this might be right for
HIV Infections
Otsuka America Pharmaceutical 36
Testing effectiveness (Phase 2)Study completedNCT00000872
What this trial is testing

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Not applicableStudy completedNCT00002172
What this trial is testing

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

Who this might be right for
HIV Infections
The Immune Response Corporation
Not applicableStudy completedNCT00002161
What this trial is testing

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

Who this might be right for
HIV Infections
Gilead Sciences 400
Testing effectiveness (Phase 2)Study completedNCT00113282
What this trial is testing

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 57
Not applicableStudy completedNCT00017771
What this trial is testing

Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs

Who this might be right for
HIV InfectionsPeripheral Nervous System Disease
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT00001063
What this trial is testing

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT00000907
What this trial is testing

Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT03666871
What this trial is testing

CCR5-modified CD4+ T Cells for HIV Infection

Who this might be right for
HIV Infections
University of Cincinnati 30
Not applicableStudy completedNCT00000859
What this trial is testing

Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,300
Early research (Phase 1)UnknownNCT00002449
What this trial is testing

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

Who this might be right for
HIV Infections
Chiron Corporation 212
Large-scale testing (Phase 3)Study completedNCT00000949
What this trial is testing

Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 460
Not applicableStudy completedNCT00000923
What this trial is testing

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 110
Not applicableUnknownNCT04208711
What this trial is testing

Role of PLA2G1B During HIV Infection

Who this might be right for
HIV Infections
Diaccurate SAS 15
Testing effectiveness (Phase 2)Study completedNCT00000909
What this trial is testing

Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT00000870
What this trial is testing

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT00002307
What this trial is testing

A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT03403569
What this trial is testing

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

Who this might be right for
HIV-infection/AIDS
Peking Union Medical College Hospital 353
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation